Senior insider sale
Chief Medical Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$2.75M
31.90K shares
What this filing means
DAMBKOWSKI CARL plans to sell 31.90K shares of APOGEE THERAPEUTICS, INC. valued at approximately $2.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/22/2026ACC: 0001950047-26-006388
Officer· Chief Medical Officer
Since Mar 2026
31.90K
Shares to sell
$2.75M
Approx. market value
15.40K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSA
N/A
12/14/2022
15.40KTotal acquired15.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/14/2022 | RSA N/A | 15.40K | — |
| Total | 15.40K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5.50K
Market value
$432.9K
6/3/2026
—Completed
Units to sell
5.50K
Market value
$462.8K
5/6/2026
—Completed
Units to sell
5.50K
Market value
$466.6K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.40K
Market value
$1.39M
6/22/2026
Total
Units
31.90K
Value
$2.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/3/2026 | 5.50K | $432.9K | — | Completed |
5/6/2026 | 5.50K | $462.8K | — | Completed |
4/1/2026 | 5.50K | $466.6K | — | Completed |
| Planned — Approximate Date | ||||
6/22/2026 | 15.40K | $1.39M | NASDAQ | Planned |
| Total | 31.90K | $2.75M | ||